Dora B. Balogh

27 Baross Street
Budapest, BU 1088, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Endometriosis as a determinant of work disability in the Hungarian population: quantifying productivity loss and the need for workplace prevention strategies.

Endometriosis as a determinant of work disability in the Hungarian population: quantifying productivity loss and the need for workplace prevention strategies.

Journal: Preventive medicine reports

Published: March 06, 2026

Gastrointestinal quality of life after low segmental rectal resection for bowel endometriosis

Gastrointestinal quality of life after low segmental rectal resection for bowel endometriosis

Journal: Orvosi hetilap

Published: January 02, 2026

Serum Galectin-1 as a Diagnostic Biomarker in Endometriosis: A Prospective Longitudinal Study.

Serum Galectin-1 as a Diagnostic Biomarker in Endometriosis: A Prospective Longitudinal Study.

Journal: International journal of molecular sciences

Published: September 26, 2025

Alteration of Serum Gal-3 Levels in Endometrium-Related Reproductive Disorders.

Alteration of Serum Gal-3 Levels in Endometrium-Related Reproductive Disorders.

Journal: International journal of molecular sciences

Published: December 25, 2024

Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Journal: International journal of molecular sciences

Published: October 31, 2024

FEMaLe: The use of machine learning for early diagnosis of endometriosis based on patient self-reported data-Study protocol of a multicenter trial.

FEMaLe: The use of machine learning for early diagnosis of endometriosis based on patient self-reported data-Study protocol of a multicenter trial.

Journal: PloS one

Published: January 21, 2024

Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.

Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.

Journal: International journal of molecular sciences

Published: November 04, 2023

An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis.

An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis.

Journal: International journal of molecular sciences

Published: March 21, 2023

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.

Journal: PloS one

Published: July 16, 2021

Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney.

Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney.

Journal: American journal of physiology. Renal physiology

Published: March 03, 2020

Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition.

Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition.

Journal: Psychoneuroendocrinology

Published: January 29, 2020

Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling.

Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling.

Journal: Diabetologia

Published: November 27, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026